Effects of low dose everolimus and/or BEZ235 on vaccine response in the elderly

Phase 2

Completed

• Conditions: Immune response to vaccination; Inflammatory and Immune System - Normal development and function of the immune system

• Registration Number: ACTRN12613001351707
• Lead Sponsor: ovartis Institutes for BioMedical Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-12-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

Informed Consent obtained
>= 65 yo, male and female
>=40kg

Exclusion Criteria

Subjects with underlying unstable medical conditions.

Study & Design

• Study Type: Interventional
• Study Design: Not specified